Skip to content

Study on the early intervention protocol of renal papillary calcium spot

Study on the early intervention protocol of renal papillary calcium spot

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055859
Enrollment
Unknown
Registered
2022-01-20
Start date
2022-01-20
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal papillary calcium spot

Interventions

Therapy group:Oral sodium potassium hydrogen citrate particles

Sponsors

Air Force Medical Center,PLA
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Subjects recruited in the clinic: 60 male patients with renal papillary calcium spot were diagnosed with CT flat scan, with a long diameter of no more than 4mm, single or multiple cases, aged 20 to 50 years. There was no previous history of urocollithiasis, no recurrent urinary infection, no urinary organic lesions, normal cardiac, lung, liver and renal function, no diabetes and hyperuricemia, and no digestive tract disease; 2. Flying personnel kidney stone patients: hospitalized pilots who diagnose kidney stones and require surgical intervention. There was no history of recurrent urinary infections, no urinary organic lesions, normal cardiac, lung, liver and renal function, and no diabetes and hyperuricemia.

Exclusion criteria

Exclusion criteria: 1. Subjects recruited in the outpatient department: combined with urinary system malformation, urinary tract infection, gastrointestinal diseases, hyperuricemia, diabetes, acute and chronic renal insufficiency, liver insufficiency, and other diseases that are easy to promote urinary calculi. In addition, there are (1) patients participating in other clinical studies; (2) the researchers think that other reasons are not suitable for clinical researchers. 2. Patients with kidney stones of flying personnel: patients with urinary system malformation, urinary system infection, hyperuricemia, diabetes, acute and chronic renal insufficiency, liver insufficiency, and other diseases easy to promote the generation of urinary calculi.

Design outcomes

Primary

MeasureTime frame
Renal papilla calcium plaque size;

Secondary

MeasureTime frame
Renal papilla calcium spot location;

Countries

China

Contacts

Public ContactLi Jianye

Air Force Medical Center, PLA

15910617543@139.com+86 15910617543

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026